Cardiovascular protection of magnolol: Cell-type specificity and dose-related effects

Journal of Biomedical Science

Volumn 19, Issue 1, 2012, Pages

  Ho, Jennifer Hui Chun ^a,b,c   Hong, Chuang Ye ^a,b  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antioxidant; Cardiomyocytes; Inflammation; Magnolol; Smooth muscle cells; Vascular endothelial cells

Indexed keywords

MAGNOLOL; BIPHENYL DERIVATIVE; HERBACEOUS AGENT; LIGNAN;

APOPTOSIS; ATHEROSCLEROSIS; CARDIOVASCULAR SYSTEM; CELL PROLIFERATION; CELL SPECIFICITY; CELL TYPE; CONCENTRATION (PARAMETERS); CORONARY ARTERY DILATATION; DRUG ACTIVITY; DRUG BIOAVAILABILITY; DRUG SAFETY; DRUG STRUCTURE; HEART MUSCLE; HEART PROTECTION; HUMAN; INFLAMMATION; MOLECULAR DYNAMICS; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; RESTENOSIS; REVIEW; SMOOTH MUSCLE FIBER; THROMBOCYTE; THROMBOCYTE AGGREGATION; THROMBOGENESIS; ARTICLE; CHEMISTRY; CYTOLOGY; DRUG EFFECT; HEART MUSCLE CELL; MAGNOLIACEAE; VASCULAR SMOOTH MUSCLE;

MAGNOLIA OFFICINALIS;

APOPTOSIS; BIPHENYL COMPOUNDS; CARDIOVASCULAR SYSTEM; DRUGS, CHINESE HERBAL; HUMANS; INFLAMMATION; LIGNANS; MAGNOLIA; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, CARDIAC; MYOCYTES, SMOOTH MUSCLE;

EID: 84864366931     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1186/1423-0127-19-70     Document Type: Review

References (62)

1. Simultaneous determination of honokiol and magnolol in Magnolia officinalis by liquid chromatography with tandem mass spectrometric detection. Wu YT, Lin LC, Tsai TH, Biomed Chromatogr 2006 20 1076 1081 10.1002/bmc.644 16583454 (Pubitemid 44697046)
2. Separation and determination of honokiol and magnolol in herbal medicines by flow injection-capillary electrophoresis. Liu L, Wu X, Fan L, Chen X, Hu Z, Anal Bioanal Chem 2006 384 1533 1539 10.1007/s00216-006-0319-3 16525846
3. Honokiol, a multifunctional antiangiogenic and antitumor agent. Fried LE, Arbiser JL, Antioxid Redox Signal 2009 11 1139 1148 10.1089/ars.2009.2440 19203212
4. Synthesis, cytotoxicity, and antiviral activities of new neolignans related to honokiol and magnolol. Amblard F, Govindarajan B, Lefkove B, Rapp KL, Detorio M, Arbiser JL, Schinazi RF, Bioorg Med Chem Lett 2007 17 4428 4431 10.1016/j.bmcl.2007.06.024 17587572 (Pubitemid 47058969)
5. Design and synthesis of novel magnolol derivatives as potential antimicrobial and antiproliferative compounds. Srinivas J, Reddy Doma M, Singh PP, Kumar S, Malik F, Sharma A, Khan IA, Qazi GN, Kumar HM, Eur J Med Chem 2012 51 35 41 22424614
6. Synthesis and radical scavenging of novel magnolol derivatives. Wang Y, Li CY, Lin IH, Lee AR, Hu MK, J Pharm Pharmacol 2002 54 1697 1703 12542902 (Pubitemid 36018821)
7. Honokiol and magnolol selectively interact with GABAA receptor subtypes in vitro. Ai J, Wang X, Nielsen M, Pharmacology 2001 63 34 41 10.1159/000056110 11408830 (Pubitemid 32623459)
8. Magnolol, a major bioactive constituent of the bark of Magnolia officinalis, exerts antiepileptic effects via the GABA/benzodiazepine receptor complex in mice. Chen CR, Tan R, Qu WM, Wu Z, Wang Y, Urade Y, Huang ZL, Br J Pharmacol 2011 164 1534 1546 10.1111/j.1476-5381.2011.01456.x 21518336
9. Magnolol and honokiol: inhibitors against mouse passive cutaneous anaphylaxis reaction and scratching behaviors. Han SJ, Bae EA, Trinh HT, Yang JH, Youn UJ, Bae KH, Kim DH, Biol Pharm Bull 2007 30 2201 2203 10.1248/bpb.30.2201 17978501 (Pubitemid 350097051)
10. Antimicrobial activity of honokiol and magnolol isolated from Magnolia officinalis. Ho KY, Tsai CC, Chen CP, Huang JS, Lin CC, Phytother Res 2001 15 139 141 10.1002/ptr.736 11268114 (Pubitemid 32290484)
11. Anticancer potential of magnolol for lung cancer treatment. Seo JU, Kim MH, Kim HM, Jeong HJ, Arch Pharm Res 2011 34 625 633 10.1007/s12272-011-0413-8 21544728
12. Magnolol and honokiol isolated from Magnolia officinalis protect rat heart mitochondria against lipid peroxidation. Lo YC, Teng CM, Chen CF, Chen CC, Hong CY, Biochem Pharmacol 1994 47 549 553 10.1016/0006-2952(94)90187-2 8117323 (Pubitemid 24071536)
13. Magnolol attenuates peroxidative damage and improves survival of rats with sepsis. Kong CW, Tsai K, Chin JH, Chan WL, Hong CY, Shock 2000 13 24 28 10.1097/00024382-200013010-00005 10638665
14. Antimicrobial activity of phenolic constituents of Magnolia grandiflora L. Clark AM, El-Feraly FS, Li WS, J Pharm Sci 1981 70 951 952 10.1002/jps.2600700833 7310672 (Pubitemid 11025588)
15. Efficient synthesis and structure-activity relationship of honokiol, a neurotrophic biphenyl-type neolignan. Esumi T, Makado G, Zhai H, Shimizu Y, Mitsumoto Y, Fukuyama Y, Bioorg Med Chem Lett 2004 14 2621 2625 10.1016/j.bmcl.2004.02.067 15109665 (Pubitemid 38515715)
16. Magnolol reduces infarct size and suppresses ventricular arrhythmia in rats subjected to coronary ligation. Hong CY, Huang SS, Tsai SK, Clin Exp Pharmacol Physiol 1996 23 660 664 10.1111/j.1440-1681.1996.tb01753.x 8886485 (Pubitemid 26373908)
17. Myocardial protective effect of honokiol: an active component in Magnolia officinalis. Tsai SK, Huang SS, Hong CY, Planta Med 1996 62 503 506 10.1055/s-2006-957957 9000881 (Pubitemid 27006682)
18. Antiarrhythmic effect of magnolol and honokiol during acute phase of coronary occlusion in anesthetized rats: influence of L-NAME and aspirin. Tsai SK, Huang CH, Huang SS, Hung LM, Hong CY, Pharmacology 1999 59 227 233 10.1159/000028324 10529654 (Pubitemid 29473847)
19. Intravenous pretreatment with magnolol protects myocardium against stunning. Huang CH, Hong CY, Tsai SK, Lai ST, Weng ZC, Chih CL, Hsieh YH, Planta Med 2000 66 516 520 10.1055/s-2000-8653 10985076 (Pubitemid 30626476)
20. Magnolol reduces myocardial ischemia/reperfusion injury via neutrophil inhibition in rats. Lee YM, Hsiao G, Chen HR, Chen YC, Sheu JR, Yen MH, Eur J Pharmacol 2001 422 159 167 10.1016/S0014-2999(01)01069-X 11430926 (Pubitemid 32595587)
21. Effect of magnolol on coronary vascular resistance in rabbits: measurement with pulsed Doppler velocimetry. Huang CH, Hong CY, Tsai SK, Lai ST, J Formos Med Assoc 2000 99 554 558 10925566
22. Anti-apoptotic effect of magnolol in myocardial ischemia and reperfusion injury requires extracellular signal-regulated kinase1/2 pathways in rat in vivo. Jin YC, Kim KJ, Kim YM, Ha YM, Kim HJ, Yun UJ, Bae KH, Kim YS, Kang SS, Seo HG, Lee JH, Chang KC, Exp Biol Med (Maywood) 2008 233 1280 1288 10.3181/0803-RM-79
23. Magnolol depresses urotensin-II-induced cell proliferation in rat cardiac fibroblasts. Liou JY, Chen YL, Loh SH, Chen PY, Hong CY, Chen JJ, Cheng TH, Liu JC, Clin Exp Pharmacol Physiol 2009 36 711 716 10.1111/j.1440-1681.2009.05144.x 19207719
24. Magnolol, a potent antioxidant from Magnolia officinalis, attenuates intimal thickening and MCP-1 expression after balloon injury of the aorta in cholesterol-fed rabbits. Chen YL, Lin KF, Shiao MS, Chen YT, Hong CY, Lin SJ, Basic Res Cardiol 2001 96 353 363 10.1007/s003950170043 11518191 (Pubitemid 32700572)
25. Magnolol induces apoptosis in vascular smooth muscle. Chen JH, Wu CC, Hsiao G, Yen MH, Naunyn Schmiedebergs Arch Pharmacol 2003 368 127 133 10.1007/s00210-003-0779-3 12898128 (Pubitemid 37041305)
26. Elucidating the inhibitory mechanisms of magnolol on rat smooth muscle cell proliferation. Wu CH, Chen CW, Chen HC, Chang WC, Shu MJ, Hung JS, J Pharmacol Sci 2005 99 392 399 10.1254/jphs.FP0050473 16340156 (Pubitemid 41813431)
27. Inhibitory role of magnolol on proliferative capacity and matrix metalloproteinase-9 expression in TNF-alpha-induced vascular smooth muscle cells. Kim HM, Bae SJ, Kim DW, Kim BK, Lee SB, Lee US, Kim CH, Moon SK, Int Immunopharmacol 2007 7 1083 1091 10.1016/j.intimp.2007.04.004 17570325 (Pubitemid 46908702)
28. Studies on the active principles of magnolia bark. Centrally acting muscle relaxant activity of magnolol and hnokiol. Watanabe K, Watanabe HY, Goto Y, Yamamoto N, Yoshizaki M, Jpn J Pharmacol 1975 25 605 607 10.1254/jjp.25.605 1221141
29. Chemostructural requirement for centrally acting muscle relaxant effect of magnolol and honokiol, neolignane derivatives. Watanabe H, Watanabe K, Hagino K, J Pharmacobiodyn 1983 6 184 190 10.1248/bpb1978.6.184 6875799 (Pubitemid 13065965)
30. EDRF-release and Ca+(+)-channel blockade by magnolol, an antiplatelet agent isolated from Chinese herb Magnolia officinalis, in rat thoracic aorta. Teng CM, Yu SM, Chen CC, Huang YL, Huang TF, Life Sci 1990 47 1153 1161 10.1016/0024-3205(90)90176-R 2172682 (Pubitemid 20353720)
31. Inhibition of smooth muscle contraction by magnolol and honokiol in porcine trachea. Ko CH, Chen HH, Lin YR, Chan MH, Planta Med 2003 69 532 536 12865972
32. The mechanism of honokiol-induced and magnolol-induced inhibition on muscle contraction and Ca2+ mobilization in rat uterus. Lu YC, Chen HH, Ko CH, Lin YR, Chan MH, Naunyn Schmiedebergs Arch Pharmacol 2003 368 262 269 10.1007/s00210-003-0802-8 14504686 (Pubitemid 37372548)
33. Protective effects of magnolol against oxidized LDL-induced apoptosis in endothelial cells. Ou HC, Chou FP, Sheu WH, Hsu SL, Lee WJ, Arch Toxicol 2007 81 421 432 10.1007/s00204-006-0172-3 17216433 (Pubitemid 46980505)
34. Inhibition of NADPH oxidase-related oxidative stress-triggered signaling by honokiol suppresses high glucose-induced human endothelial cell apoptosis. Sheu ML, Chiang CK, Tsai KS, Ho FM, Weng TI, Wu HY, Liu SH, Free Radic Biol Med 2008 44 2043 2050 10.1016/j.freeradbiomed.2008.03.014 18423412
35. Inhibitors of nitric oxide synthesis and TNF-alpha expression from Magnolia obovata in activated macrophages. Son HJ, Lee HJ, Yun-Choi HS, Ryu JH, Planta Med 2000 66 469 471 10.1055/s-2000-8592 10909270 (Pubitemid 30413511)
36. Magnolol induces cytosolic-free Ca2+ elevation in rat neutrophils primarily via inositol trisphosphate signalling pathway. Wang JP, Chen CC, Eur J Pharmacol 1998 352 329 334 10.1016/S0014-2999(98)00363-X 9716370 (Pubitemid 28345133)
37. Magnolol inhibits Mac-1 (CD11b/CD18)-dependent neutrophil adhesion: relationship with its antioxidant effect. Shen YC, Sung YJ, Chen CF, Eur J Pharmacol 1998 343 79 86 10.1016/S0014-2999(97)01519-7 9551717 (Pubitemid 28161054)
38. Possible involvement of protein kinase c inhibition in the reduction of phorbol ester-induced neutrophil aggregation by magnolol in the rat. Wang JP, Lin PL, Hsu MF, Chen CC, J Pharm Pharmacol 1998 50 1167 1172 9821665 (Pubitemid 28488137)
39. Salvianolic acid B attenuates VCAM-1 and ICAM-1 expression in TNF-alpha-treated human aortic endothelial cells. Chen YH, Lin SJ, Ku HH, Shiao MS, Lin FY, Chen JW, Chen YL, J Cell Biochem 2001 82 512 521 10.1002/jcb.1176 11500927 (Pubitemid 32729414)
40. Magnolol attenuates VCAM-1 expression in vitro in TNF-alpha-treated human aortic endothelial cells and in vivo in the aorta of cholesterol-fed rabbits. Chen YH, Lin SJ, Chen JW, Ku HH, Chen YL, Br J Pharmacol 2002 135 37 47 10.1038/sj.bjp.0704458 11786478
41. Herbal remedy magnolol suppresses IL-6-induced STAT3 activation and gene expression in endothelial cells. Chen SC, Chang YL, Wang DL, Cheng JJ, Br J Pharmacol 2006 148 226 232 10.1038/sj.bjp.0706647 16520748 (Pubitemid 43873041)
42. Two antiplatelet agents from Magnolia officinalis. Teng CM, Chen CC, Ko FN, Lee LG, Huang TF, Chen YP, Hsu HY, Thromb Res 1988 50 757 765 10.1016/0049-3848(88)90336-2 3413728
43. Magnolol inhibits collagen-induced platelet serotonin release. Tsai TH, Tsai WJ, Chou CJ, Chen CF, Thromb Res 1995 78 265 270 10.1016/0049-3848(95) 90878-J 7543220
44. Development of a novel method for determination of acetyl-CoA:1-alkyl-sn- glycero-3-phosphocholine acetyltransferase activity and its application to screening for acetyltransferase inhibitors, Inhibition by magnolol and honokiol from Magnoliae cortex. Yamazaki R, Sugatani J, Fujii I, Kuroyanagi M, Umehara K, Ueno A, Suzuki Y, Miwa M, Biochem Pharmacol 1994 47 995 1006 10.1016/0006-2952(94)90410-3 8147919
45. Disposition of magnolol after intravenous bolus and infusion in rabbits. Tsai TH, Chou CJ, Chen CF, Drug Metab Dispos 1994 22 518 521 7956724
46. Pharmacokinetics and brain distribution of magnolol in the rat after intravenous bolus injection. Tsai TH, Chou CJ, Chen CF, J Pharm Pharmacol 1996 48 57 59 8722496 (Pubitemid 26128686)
47. High-performance liquid chromatographic method for simultaneous determination of honokiol and magnolol in rat plasma. Wu X, Chen X, Hu Z, Talanta 2003 59 115 121 10.1016/S0039-9140(02)00470-8 18968891
48. Simultaneous determination of the 10 major components of Da-Cheng-Qi decoction in dog plasma by liquid chromatography tandem mass spectrometry. Yu Q, Xiang J, Tang W, Liang M, Qin Y, Nan F, J Chromatogr B Analyt Technol Biomed Life Sci 2009 877 2025 2031 10.1016/j.jchromb.2009.05.030 19523886
49. Pharmacokinetic and pharmacodynamic studies of magnolol after oral administration in rats. Tsai TH, Chou CJ, Lee TF, Wang LCH, Chen CF, Pharmaceut Sci 1996 2 191 193 (Pubitemid 28121805)
50. Pharmacokinetics, bioavailability, and tissue distribution of magnolol following single and repeated dosing of magnolol to rats. Lin SP, Tsai SY, Lee Chao PD, Chen YC, Hou YC, Planta Med 2011 77 1800 1805 10.1055/s-0030-1271159 21638244
51. Systematic analysis of post-administrative saiboku-to urine by liquid chromatography to determine pharmacokinetics of traditional Chinese medicine. Homma M, Oka K, Taniguchi C, Niitsuma T, Hayashi T, Biomed Chromatogr 1997 11 125 131 10.1002/(SICI)1099-0801(199705)11:3<125::AID-BMC631>3.0.CO;2-L 9192103 (Pubitemid 27248419)
52. Evaluation of the in vitro and in vivo genotoxicity of magnolia bark extract. Li N, Song Y, Zhang W, Wang W, Chen J, Wong AW, Roberts A, Regul Toxicol Pharmacol 2007 49 154 159 10.1016/j.yrtph.2007.06.005 17692444 (Pubitemid 350087392)
53. Evaluation of short-term and subchronic toxicity of magnolia bark extract in rats. Liu Z, Zhang X, Cui W, Zhang X, Li N, Chen J, Wong AW, Roberts A, Regul Toxicol Pharmacol 2007 49 160 171 10.1016/j.yrtph.2007.06.006 17692445 (Pubitemid 350087393)
54. Pharmacology and toxicology of herbal medicine: subacute toxicity of commonly used Chinese drugs. Yang HY, Chen CF, J Toxicol Sci 1998 23 Suppl 2 229 233 9760471
55. Hangekobokuto (Banxia-houpo-tang), a Kampo Medicine that Treats Functional Dyspepsia. Oikawa T, Ito G, Hoshino T, Koyama H, Hanawa T, Evid Based Complement Alternat Med 2009 6 375 378 10.1093/ecam/nem101 18955239
56. Effect of a proprietary Magnolia and Phellodendron extract on weight management: a pilot, double-blind, placebo-controlled clinical trial. Garrison R, Chambliss WG, Altern Ther Health Med 2006 12 50 54 16541997 (Pubitemid 43100350)
57. Toll-like receptors: new players in myocardial ischemia/reperfusion injury. Ha T, Liu L, Kelley J, Kao R, Williams D, Li C, Antioxid Redox Signal 2011 15 1875 1893 10.1089/ars.2010.3723 21091074
58. MicroRNAs: new players in cardiac injury and protection. Kukreja RC, Yin C, Salloum FN, Mol Pharmacol 2011 80 558 564 10.1124/mol.111.073528 21737570
59. Mitochondrial involvement in cardiac apoptosis during ischemia and reperfusion: can we close the box? Machado NG, Alves MG, Carvalho RA, Oliveira PJ, Cardiovasc Toxicol 2009 9 211 227 10.1007/s12012-009-9055-1 19855945
60. Cell biology and lipoproteins in atherosclerosis. Badimon L, Martínez-González J, Llorente-Cortés V, Rodríguez C, Padrá T, Curr Mol Med 2006 6 439 456 10.2174/156652406778018725 16918367
61. Complex regulation and function of the inflammatory smooth muscle cell phenotype in atherosclerosis. Orr AW, Hastings NE, Blackman BR, Wamhoff BR, J Vasc Res 2010 47 168 180 10.1159/000250095 19851078
62. Leducq Transatlantic Network on Atherothrombosis: Inflammation in atherosclerosis: from pathophysiology to practice. Libby P, Ridker PM, Hansson GK, J Am Coll Cardiol 2009 54 2129 2138 10.1016/j.jacc.2009.09.009 19942084